Key result
Longer Type 2 diabetes duration linked to ~50% absolute increase in cardiovascular autonomic neuropathy prevalence.
Why the study?
Cardiac autonomic neuropathy causes silent myocardial infarction and sudden death in diabetics, so recognizing early asymptomatic cardiac dysautonomia could help delay or arrest progression.
Does QTc prolongation correlate with cardiovascular autonomic neuropathy in patients with Type 2 Diabetes Mellitus?
Cross-Sectional (n=120)
No
Does QTc prolongation correlate with cardiovascular autonomic neuropathy in patients with Type 2 Diabetes Mellitus?
Answers are grounded in this paper and cite their sources.
QTc interval prolongation on ECG correlates significantly with cardiovascular autonomic dysfunction in Type 2 diabetes and may serve as a diagnostic tool for cardiac autonomic neuropathy.
Background: Presence of cardiac autonomic neuropathy (CAN) is responsible for silent myocardial infarction and sudden death in diabetics. Hence recognizing cardiac dysautonomia early, which is asymptomatic will help to delay or arrest its progression.Methods: A cross-sectional study to evaluate the Prevalence of Cardiovascular Autonomic Neuropathy in Type 2 diabetes and correlate it with duration of Diabetes and to investigate the relationship between cardiac autonomic dysfunction and corrected QT interval.Results: In the study population, the prevalence of definite CAN was 8%, 24% and 58% in group A, B and C respectively. The prevalence of definite CAN increases with increase in duration of diabetes. P value <0.001 significant.Conclusions: A significant correlation is present between Cardiovascular autonomic dysfunction and QTc prolongation. QTc interval in the ECG can be used to diagnose Cardiovascular autonomic neuropathy with a reasonable sensitivity and specificity.
No takes yet. Share an insight, caveat, or question.
Inapakolla et al. (2019) conducted a cross-sectional in Type 2 Diabetes Mellitus (n=120). Duration of Type 2 Diabetes vs. <5 years duration was evaluated on Prevalence of definite cardiovascular autonomic neuropathy (CAN) (p=<0.001). The prevalence of definite cardiovascular autonomic neuropathy increased with the duration of Type 2 diabetes, rising from 8% at <5 years to 58% at >10 years.
Synapse has enriched 10 related papers. Consider them for comparative context: